Article: How Machine-Learning Tools Hold the Key to Unlocking Novel Insights

The scale and threat of the pandemic has led to the need for rapid analysis of Covid-19. Advanced technologies such as artificial intelligence and machine learning are playing a large role in this process, and with other diseases, too, accelerating scientific research to enable major breakthroughs. Read our full article with BiopharmaTrend on the importance […]

Article: Automated flow cytometry can expedite the discovery and development of next-gen drugs

Automated workflows offer a number of advantages to pharmaceutical companies that can integrate them to accelerate drug discovery and development. Our latest article with The Science Advisory Board explains why automated gating in flow cytometry presents researchers with huge advantages compared to manual gating techniques. Read the full article here.

Interview: Data lifecycle and automated gating

Our Chief Product Officer, Satnam Surae recently spoke to Bioanalysis Zone about the importance of flow cytometry in pharmaceutical research and what the future holds for the technique. You can read the full interview here and contact the team for more information on how we can support your R&D efforts.

Article: Automated flow cytometry analysis tools unlock pharma research insights

As pharmaceutical companies expand their research and development (R&D) efforts to meet the growing global demand for new drugs, the need for efficient analysis of preclinical and clinical research data is becoming a priority. Take a look at our article with Drug Discovery World which discusses the challenges of the large volume of data generated […]

Article: Bridging the automation gap

As technology innovation progresses at a rapid pace, laboratory automation will continue to permeate a broad range of sectors, from genomics and proteomics to drug discovery and clinical diagnostics, for the foreseeable future. Our article with European Pharmaceutical Manufacturer, discusses how automation can benefit the pharma industry when it comes to data processing and analytics. […]

Interview: Expediting drug discovery through advanced machine learning

Our Chief Product Officer, Satnam Surae, has spoken to Biopharma Trend about how Aigenpulse is helping life science organisations use advanced machine learning technologies to expedite their drug discovery processes. Take a look at the full interview here, and get in touch to find out more about how we can help you.